Key Adverse Events Following Childhood Cancer

S
Sandeep Batra, MD

Primary Investigator

Overview

The goal of this study is to identify subjects who are more likely to develop a late-occurring complication(s) after undergoing treatment for childhood cancer.

Description

The purpose of this study is to identify key adverse events developing in patients (cases) with a primary cancer diagnosed at age 21 or younger.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    childhood cancer
  • Age: - 21 Years
  • Gender: All

Inclusion Criteria
Diagnosis of primary cancer at age 21 or younger
In active follow-up by a Children's Oncology Group (COG) institution
Development of one of the following key adverse events after initiation of prior cancer therapy:Cardiac dysfunction, Myocardial infarction, Ischemic stroke, Avascular necrosis, Subsequent malignant neoplasm
Exclusion Criteria
Prior allogeneic (non-autologous) hematopoietic cell transplant
Additional Information:
Participants will not be paid for their participation.

Updated on 09 Mar 2024. Study ID: 1011003233 (PHO-COG-FALLON-ALTE03N1)

Connect with a study center near you

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center